Alan Scott Industries Share Price
Sector: Medical Equipment & Supplies
104.00 +0.13 (0.13%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
102.00
Today’s High
106.00
52 Week Low
47.02
52 Week High
186.29
Key Metrics
- Market Cap (In Cr) 57.13
- Beta -0.39
- Div. Yield (%) 0
- P/B 29.39
- TTM P/E -
- Sector P/E 31.01
- D/E 0.04
- Open Price 103
- Prev Close 103.87
Alan Scott Industries Analysis
Price Analysis
-
1 Week9.71%
-
3 Months-19.71%
-
6 Month-38.86%
-
YTD-41.22%
-
1 Year92.73%
Risk Meter
- 60% Low risk
- 60% Moderate risk
- 60% Balanced Risk
- 60% High risk
- 60% Extreme risk
Alan Scott Industries Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 28.69
- Selling/ General/ Admin Expenses Total
- 3.78
- Depreciation/ Amortization
- 3.8
- Other Operating Expenses Total
- 5.72
- Total Operating Expense
- 30.56
- Operating Income
- -1.87
- Net Income Before Taxes
- -1.82
- Net Income
- -1.82
- Diluted Normalized EPS
- -3.36
- Period
- 2025
- Total Assets
- 27.25
- Total Liabilities
- 25.48
- Total Equity
- 1.77
- Tangible Book Valueper Share Common Eq
- 3.58
- Period
- 2025
- Cashfrom Operating Activities
- -0.32
- Cashfrom Investing Activities
- -1.26
- Cashfrom Financing Activities
- -0.15
- Net Changein Cash
- -1.74
- Period
- 2024
- Total Revenue
- 11.5
- Selling/ General/ Admin Expenses Total
- 1.85
- Depreciation/ Amortization
- 2.41
- Other Operating Expenses Total
- 2.7
- Total Operating Expense
- 14.02
- Operating Income
- -2.51
- Net Income Before Taxes
- -3.5
- Net Income
- -3.5
- Diluted Normalized EPS
- -7.63
- Period
- 2024
- Total Assets
- 27.84
- Total Liabilities
- 24.49
- Total Equity
- 3.36
- Tangible Book Valueper Share Common Eq
- 6.76
- Period
- 2024
- Cashfrom Operating Activities
- -3.11
- Cashfrom Investing Activities
- -3.05
- Cashfrom Financing Activities
- 8.53
- Net Changein Cash
- 2.37
- Period
- 2023
- Total Revenue
- 5.22
- Selling/ General/ Admin Expenses Total
- 1.11
- Depreciation/ Amortization
- 1.08
- Other Operating Expenses Total
- 1.38
- Total Operating Expense
- 6.87
- Operating Income
- -1.65
- Net Income Before Taxes
- -2.06
- Net Income
- -2.06
- Diluted Normalized EPS
- -7.71
- Period
- 2023
- Total Assets
- 10.39
- Total Liabilities
- 9.2
- Total Equity
- 1.19
- Tangible Book Valueper Share Common Eq
- 4.79
- Period
- 2023
- Cashfrom Operating Activities
- -1.57
- Cashfrom Investing Activities
- -3.48
- Cashfrom Financing Activities
- 4.72
- Net Changein Cash
- -0.33
- Period
- 2022
- Total Revenue
- 1.24
- Selling/ General/ Admin Expenses Total
- 0.25
- Depreciation/ Amortization
- 0.05
- Other Operating Expenses Total
- 0.63
- Total Operating Expense
- 1.95
- Operating Income
- -0.71
- Net Income Before Taxes
- -0.06
- Net Income
- -0.06
- Diluted Normalized EPS
- -0.27
- Period
- 2022
- Total Assets
- 5.57
- Total Liabilities
- 2.49
- Total Equity
- 3.08
- Tangible Book Valueper Share Common Eq
- 12.38
- Period
- 2022
- Cashfrom Operating Activities
- -1.58
- Cashfrom Investing Activities
- -0.95
- Cashfrom Financing Activities
- 1.73
- Net Changein Cash
- -0.8
- Period
- 2021
- Total Revenue
- 0.02
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.1
- Total Operating Expense
- 0.11
- Operating Income
- -0.09
- Net Income Before Taxes
- 0
- Net Income
- 0
- Diluted Normalized EPS
- 0.04
- Period
- 2021
- Total Assets
- 1.6
- Total Liabilities
- 0.06
- Total Equity
- 1.53
- Tangible Book Valueper Share Common Eq
- 9.5
- Period
- 2021
- Cashfrom Operating Activities
- 0.18
- Cashfrom Investing Activities
- -0.21
- Cashfrom Financing Activities
- 1.29
- Net Changein Cash
- 1.26
- Period
- 2020
- Total Revenue
- 0.05
- Selling/ General/ Admin Expenses Total
- 0.02
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.09
- Total Operating Expense
- 0.11
- Operating Income
- -0.06
- Net Income Before Taxes
- -0.07
- Net Income
- -0.07
- Diluted Normalized EPS
- -0.73
- Period
- 2020
- Total Assets
- 0.29
- Total Liabilities
- 0.01
- Total Equity
- 0.28
- Tangible Book Valueper Share Common Eq
- 2.99
- Period
- 2020
- Cashfrom Operating Activities
- -0.05
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.05
- Period
- 2019
- Total Revenue
- 0.12
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.09
- Total Operating Expense
- 0.11
- Operating Income
- 0.01
- Net Income Before Taxes
- 0.01
- Net Income
- 0.01
- Diluted Normalized EPS
- 0.07
- Period
- 2019
- Total Assets
- 0.35
- Total Liabilities
- 0
- Total Equity
- 0.35
- Tangible Book Valueper Share Common Eq
- 3.72
- Period
- 2019
- Cashfrom Operating Activities
- 0.06
- Cashfrom Investing Activities
- 0.02
- Cashfrom Financing Activities
- -0.02
- Net Changein Cash
- 0.05
- Period
- 2025-03-31
- Total Revenue
- 8.14
- Selling/ General/ Admin Expenses Total
- 1.04
- Depreciation/ Amortization
- 1.11
- Other Operating Expenses Total
- 1.96
- Total Operating Expense
- 8.54
- Operating Income
- -0.39
- Net Income Before Taxes
- -0.95
- Net Income
- -0.95
- Diluted Normalized EPS
- -1.93
- Period
- 2025-03-31
- Total Assets
- 27.25
- Total Liabilities
- 25.48
- Total Equity
- 1.77
- Tangible Book Valueper Share Common Eq
- 3.58
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -0.32
- Cashfrom Investing Activities
- -1.26
- Cashfrom Financing Activities
- -0.15
- Net Changein Cash
- -1.74
- Period
- 2024-12-31
- Total Revenue
- 7.81
- Selling/ General/ Admin Expenses Total
- 1.1
- Depreciation/ Amortization
- 0.97
- Other Operating Expenses Total
- 1.69
- Total Operating Expense
- 8.58
- Operating Income
- -0.78
- Net Income Before Taxes
- 0.55
- Net Income
- 0.55
- Diluted Normalized EPS
- 1.11
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 6.76
- Selling/ General/ Admin Expenses Total
- 0.83
- Depreciation/ Amortization
- 0.85
- Other Operating Expenses Total
- 1.12
- Total Operating Expense
- 6.99
- Operating Income
- -0.23
- Net Income Before Taxes
- -0.55
- Net Income
- -0.55
- Diluted Normalized EPS
- -1.18
- Period
- 2024-09-30
- Total Assets
- 28.11
- Total Liabilities
- 26.06
- Total Equity
- 2.05
- Tangible Book Valueper Share Common Eq
- 4.14
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -2.04
- Cashfrom Investing Activities
- -1.01
- Cashfrom Financing Activities
- 0.94
- Net Changein Cash
- -2.12
- Period
- 2024-06-30
- Total Revenue
- 6.14
- Selling/ General/ Admin Expenses Total
- 0.82
- Depreciation/ Amortization
- 0.86
- Other Operating Expenses Total
- 0.98
- Total Operating Expense
- 6.64
- Operating Income
- -0.5
- Net Income Before Taxes
- -0.86
- Net Income
- -0.86
- Diluted Normalized EPS
- -1.62
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 4.26
- Selling/ General/ Admin Expenses Total
- 0.6
- Depreciation/ Amortization
- 0.87
- Other Operating Expenses Total
- 1.22
- Total Operating Expense
- 4.9
- Operating Income
- -0.64
- Net Income Before Taxes
- -1.12
- Net Income
- -1.12
- Diluted Normalized EPS
- -4.33
- Period
- 2024-03-31
- Total Assets
- 27.84
- Total Liabilities
- 24.49
- Total Equity
- 3.36
- Tangible Book Valueper Share Common Eq
- 6.76
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -3.11
- Cashfrom Investing Activities
- -3.05
- Cashfrom Financing Activities
- 8.53
- Net Changein Cash
- 2.37
- Period
- 2023-12-31
- Total Revenue
- 3.66
- Selling/ General/ Admin Expenses Total
- 0.6
- Depreciation/ Amortization
- 0.67
- Other Operating Expenses Total
- 0.73
- Total Operating Expense
- 4.49
- Operating Income
- -0.83
- Net Income Before Taxes
- -0.95
- Net Income
- -0.95
- Diluted Normalized EPS
- -1.82
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Alan Scott Industries Technical
Moving Average
SMA
- 5 Day98.31
- 10 Day102.94
- 20 Day101.95
- 50 Day110.99
- 100 Day114.99
- 300 Day117.59
Alan Scott Industries Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Rajnish Wellness
- 0.86
- 0.01
- 1.18
- 6.36
- 0.83
- 107.95
- Maestros Electrncs & Telecom Sys
- 140.65
- -2.55
- -1.78
- 262.15
- 113.4
- 77.67
- Alan Scott Industries
- 104
- 0.13
- 0.13
- 186.29
- 47.02
- 57.13
- Centenial Surgical Suture
- 147.1
- -1.55
- -1.04
- 169.5
- 82.15
- 53.66
- Gkb Ophthalmics
- 74.97
- -1.13
- -1.48
- 131.75
- 59
- 37.84
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Rajnish Wellness
- 369.57
- 0.78
- 0.82
- 1.13
- Maestros Electrncs & Telecom Sys
- 18.04
- 2.26
- 15.24
- 13.13
- Alan Scott Industries
- -
- 29
- -72.98
- -15.92
- Centenial Surgical Suture
- -
- 1.76
- 1.4
- 0.9
- Gkb Ophthalmics
- -
- 0.74
- -3.18
- -2.4
Alan Scott Industries Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-May-25
- Audited Results
- 24-Apr-25
- Others
- 30-Jan-25
- Quarterly Results
- 07-Nov-24
- Quarterly Results
- 14-Aug-24
- Quarterly Results & Rights issue
- 29-May-24
- Audited Results
- 09-Feb-24
- Quarterly Results
- 07-Nov-23
- Quarterly Results
- 31-Oct-23
- Others
- 29-Jul-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 28-Sept-24
- 16-Sept-24
- AGM
- 25-Sept-23
- 01-Sept-23
- AGM
- 31-Jul-21
- 08-Jul-21
- AGM
- 01-Mar-21
- 08-Feb-21
- EGM
- -
- 09-Feb-24
- Others



- Announced on
- Record Date
- Ex-Rights Date
- Ratio
- FV
- Premium
- Description
- 14-Aug-24
- 02-May-25
- 02-May-25
- 1:2
- 10
- 30
- Rights issue of equity shares of Rs. 10/- in the ratio of 1:2 @ premium of Rs. 30/-.
- 18-Nov-22
- 16-Jun-23
- 16-Jun-23
- 1:1
- 10
- 20
- Rights issue of equity shares of Rs. 10/- in the ratio of 1:1 @ premium of Rs. 20/-.